AccessibilityHelpAbout Us
Abrdn Healthcare Investors logo

Abrdn Healthcare Investors(NYSE) HQH

Market Cap$1.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1987)+5,198%
5 Year+42%
1 Year+44%
1 Month-8%
$21.60
-1.95%
-0.43Today
Abrdn Healthcare Investors last closing stock price
MetricPriceDate
Last closeUSD 21.602026-09-23
Abrdn Healthcare Investors stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.31%USD 21.322026-09-16
1 month-7.65%USD 23.392026-08-24
3 month+4.62%USD 20.652026-06-25
Year to date+24.74%USD 17.322025-12-31
1 year+43.54%USD 15.052025-09-23
3 year+100.98%USD 10.752023-09-22
5 year+42.36%USD 15.172021-09-24
Since inception+5,197.74%USD 0.421987-04-23

Abrdn Healthcare Investors Financials at a Glance

Market Cap

$1.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$32.46M

Net Income (TTM)

$331.56M

EPS (TTM)

$4.55

P/E Ratio

4.84

Dividend

$2.47

Beta (Volatility)

0.71 (Low)

Price

$21.60

Volume

93,405.825

Open

$22.10

Previous Close

$21.60

Daily Range

$21.53 - $22.18

52-Week Range

$16.98 - $24.85

Estimated Earnings Date

N/A

HQH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund focused on investing in the healthcare sector. The fund primarily targets growth stocks of small-cap companies in biotechnology, medical devices, and pharmaceuticals.

Products and Services
  • Invests in public equity markets globally
  • Focuses on small-cap growth stocks in healthcare
  • Employs fundamental analysis for investment decisions
Growth Outlook
  • Strong demand for healthcare innovations drives investment opportunities
  • Healthcare sector expected to grow significantly over the next decade
  • Focus on biotechnology and medical devices aligns with market trends
Financial Highlights
  • Recent quarterly revenue of $17.03 million shows strong performance
  • Trailing twelve months (TTM) dividend yield of 11.41% indicates attractive returns
  • Net income for the latest quarter reached $79.33 million, reflecting robust profitability
Abrdn Healthcare Investors has established itself as a key player in the healthcare investment landscape. The focus on small-cap growth stocks allows the fund to capitalize on emerging companies with high potential. The healthcare sector's anticipated growth presents numerous opportunities for investors, particularly in biotechnology and medical devices. Recent financial performance highlights, including a significant quarterly revenue and a strong dividend yield, underscore the fund's commitment to delivering value to its investors. The strategic approach to investment, combined with a favorable market outlook, positions Abrdn Healthcare Investors as a compelling option for those interested in the healthcare sector.
AI Generated • Sep 18, 2026

Industry

Capital Markets

Sector

Financials

Website

www.teklacap.com/hqh.html

Headquarters

Philadelphia, PA 19103, US

HQH Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

98.80%

Net Income Margin

98.80%

Return on Equity

9.16%

Return on Capital

9.02%

Return on Assets

8.99%

Earnings Yield

20.66%

Dividend Yield

11.21%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

57.19M

Volume

93.41K

Avg. Volume

220.64K

Financials (TTM)

Gross Profit

$27.34M

Operating Income

$172.20M

EBITDA

$173.45M

Operating Cash Flow

$8.72M

Capital Expenditure

$0.00

Free Cash Flow

$8.72M

Cash & ST Invst.

$59.00

Total Debt

$0.00

Abrdn Healthcare Investors Performance Analysis

Abrdn Healthcare Investors annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 74,646,357-16.2%
20232023-09-30USD 100,444,65534.6%
20242024-09-30USD 58,532,694-41.7%
20252025-09-30USD 33,576,474-42.6%
Abrdn Healthcare Investors sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-17.1%
Q22024-06-3013.8%
Q42024-12-313.0%
Q42026-03-31N/A
Abrdn Healthcare Investors annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD -4.10N/A
20232023-09-30USD 1.14N/A
20242024-09-30USD 3.55211.4%
20252025-09-30USD 1.78-49.9%
Abrdn Healthcare Investors sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-130.8%
Q22024-06-30471.7%
Q42024-12-31-19.3%
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$17.03M

+202.6%

Gross Profit

$11.90M

+111.5%

Gross Margin

69.90%

N/A

Market Cap

$1.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$173.45M

+108.6%

EBITDA

$173.45M

N/A

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$59.00

-94.4%

Total Debt

$0.00

-100.0%

Accounts Receivable

$13.79K

-90.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

8.99%

N/A

Return on Invested Capital

9.00%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

$0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TRINTrinity Capital Inc.
$17.55-1.63%
KBDCKayne Anderson BDC, Inc.
$13.08-0.46%
VRTSVirtus Investment Partners, Inc.
$128.00-1.77%
CGBDCarlyle Secured Lending, Inc.
$11.22-2.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
WBDWarner Bros. Discovery
$30.76-0.23%
WHLRWheeler Real Estate Investment Trust
$5.44+190.91%
NVDANvidia
$225.51-1.47%
INTCIntel
$122.60-1.02%

Questions About HQH

What is the current price of Abrdn Healthcare Investors?

Abrdn Healthcare Investors is trading at $21.60 per share.

What is the 52-week range for Abrdn Healthcare Investors?

Over the past 52 weeks, Abrdn Healthcare Investors has traded between $16.98 and $24.85.

How much debt does Abrdn Healthcare Investors have?

As of the most recent reporting period, Abrdn Healthcare Investors reported total debt of $0.00.

How much cash does Abrdn Healthcare Investors have on hand?

Abrdn Healthcare Investors reported $59.00 in cash and cash equivalents in its most recent financial results.

What is Abrdn Healthcare Investors’s dividend yield?

Abrdn Healthcare Investors currently has a dividend yield of 11.21%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services